Skip to content

PressReach

SEARCH icon
  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos
Search

SEARCH FOR AN ARTICLE

  • Investing
  • Featured
  • Market
  • Biotech
  • Oil & Gas
  • Mining
  • Gaming
  • Tech
  • Crypto
  • More
    • Health
    • Entertainment
    • Real Estate
    • Cannabis
    • ESG
    • Financial
    • Food & Beverage
    • Industrials
    • Travel & Hospitality
    • Trading Tips
    • Investing Videos

PressReach

icon

      HomeHealth

      Health

      Biora Therapeutics Announces $9.75 Million Direct Offering
      Health

      Biora Therapeutics Announces $9.75 Million Direct Offering

      November 8, 2022
      Compugen’s COM701 (anti-PVRIG) Induces Potent Immune Activation in MSS-CRC Patients
      Health

      Compugen’s COM701 (anti-PVRIG) Induces Potent Immune Activation in MSS-CRC Patients

      November 8, 2022
      Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results
      Health

      Fulcrum Therapeutics Announces Recent Business Highlights and Third Quarter 2022 Financial Results

      November 8, 2022
      Welltower Announces the Formation of Joint Venture with Integra Health and Plan to Transition Skilled Nursing Assets Currently Operated by ProMedica
      Health

      Welltower Announces the Formation of Joint Venture with Integra Health and Plan to Transition Skilled Nursing Assets Currently Operated by ProMedica

      November 8, 2022
      Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH
      Health

      Eisai to Divest Rights for Muscle Relaxant Myonal, Vertigo, and Equilibrium Disturbance Treatment Merislon in Asia to DKSH

      November 7, 2022
      Tonix Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights
      Health

      Tonix Pharmaceuticals Reports Third Quarter 2022 Financial Results and Operational Highlights

      November 7, 2022
      Trevena to Release Third Quarter 2022 Financial Results on November 9, 2022
      Health

      Trevena to Release Third Quarter 2022 Financial Results on November 9, 2022

      November 7, 2022
      Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care
      Health

      Amarin Highlights Key Data Presented at American Heart Association 2022 Scientific Sessions for VASCEPA®/VAZKEPA (icosapent ethyl) and Patient Care

      November 7, 2022
      Akebia Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights
      Health

      Akebia Therapeutics Reports Third Quarter 2022 Financial Results and Recent Business Highlights

      November 5, 2022
      Eisai’s Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer’s Disease, in Thailand
      Health

      Eisai’s Sales Subsidiary Collaborates with Thai Life Insurance to Support Access to Treatments for Dementia, Including Alzheimer’s Disease, in Thailand

      November 5, 2022
      « 1 … 219 220 221 222 223 … 256 »

       

      LATEST NEWS

      • Health Sanofi Market Potential Boosted by Amvuttra Data

      PressReach

      All logos, trade names and/or trademarks, artwork and associated imagery are trademarks and/or copyright material of their respective owners.

      • Advertisers
      • Privacy Policy
      • Terms of Use
      • DMCA Policy
      • Disclaimer
      • Contact Us

      SUBSCRIBE

      To get email updates from PressReach.

      I want e-mail alerts, updates, and offers and agree to the PressReach privacy policy.

      Market Jar Media Inc. © 2026